How much funding has Arda Therapeutics raised?

Arda Therapeutics has raised $86.0M in total funding, most recently a Series A round.

When was Arda Therapeutics founded?

Arda Therapeutics was founded in 2021.

Where is Arda Therapeutics headquartered?

Arda Therapeutics is headquartered in San Carlos, California, United States.

What industry is Arda Therapeutics in?

Arda Therapeutics operates in Healthcare, Biotech, Artificial Intelligence.

How many employees does Arda Therapeutics have?

Arda Therapeutics has 1-10 employees.

Arda Therapeutics

Q: Who are Arda Therapeutics's investors?

Arda Therapeutics's investors include Andreessen Horowitz, Two Sigma Ventures, GV, Eli Lilly.

formerly Arda

Targeting cells to treat disease

San Carlos, United States · Founded 2021 · $86.0M raised

Healthcare

Biotech

Artificial Intelligence

Headquarters: San Carlos, California
Employees: 1–10
Founded: 2021
Business Model: B2B

Website: ardatx.com
Total Funding: $86.0M
Last Round: $43.0M Series AOct 2024
Rounds: 3

About

Arda Therapeutics is pioneering targeted cell depletion to treat chronic diseases of aging. Using single-cell computational biology, the company identifies specific pathogenic cell sub-populations driving conditions such as fibrosis, inflammation, and metabolic disease, then designs precision therapies to eliminate those cells without affecting healthy tissue. Founded in 2021 by Adam Freund, Ph.D., Arda is headquartered in San Carlos, California and secured a $43M Series A in October 2025 to advance its targeted cell depletion platform.

Summary

Arda Therapeutics is a Healthcare company based in San Carlos, United States, founded in 2021. It has raised $86.0M in total across 3 rounds, most recently a $43.0M Series A round in Oct 2024. Investors include Andreessen Horowitz, Two Sigma Ventures and GV.